Amplifon (AMFPF) Stock Forecast & Price Target

AMFPF Forecast - Frequently Asked Questions

Should I buy or sell Amplifon stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amplifon in the last twelve months. There is currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AMFPF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMFPF, but not buy additional shares or sell existing shares.

Does Amplifon's stock price have much downside?

According to analysts, Amplifon's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Has Amplifon been upgraded by Wall Street analysts recently?

Over the previous 90 days, Amplifon's stock had 1 upgrade by analysts.

What analysts cover Amplifon?

Amplifon has been rated by research analysts at The Goldman Sachs Group in the past 90 days.

Do Wall Street analysts like Amplifon more than its competitors?

Analysts like Amplifon less than other "medical" companies. The consensus rating for Amplifon is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AMFPF compares to other companies.